COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,389 Articles (22,816 medRxiv, 8,573 bioRxiv)

Most recent first Previous |  Page 2966: Articles 29651-29660  | Next

Serum Mycoplasma Pneumoniae IgG in COVID-19: A Protective Factor
Mi, B., Chen, L., Panayi, A. C., Xiong, Y., Liu, G.
10.1101/2020.04.12.20060079 — Posted: 2020-04-17
Monitoring and predicting viral dynamics in SARS-CoV-2-infected Patients
wen, s., Wang, Y.
10.1101/2020.04.14.20060491 — Posted: 2020-04-17
Delayed clearance of SARS-CoV2 in male compared to female patients: High ACE2 expression in testes suggests possible existence of gender-specific viral reservoirs
Shastri, A., Wheat, J., Agrawal, S., Chaterjee, N., Pradhan, K., Goldfinger, M., Kornblum, N., Steidl, U., Verma, A., Shastri, J.
10.1101/2020.04.16.20060566 — Posted: 2020-04-17 Discussion: Onsite
Neutralising antibodies to SARS coronavirus 2 in Scottish blood donors - a pilot study of the value of serology to determine population exposure
Thompson, C., Grayson, N., Paton, R., Lourenco, J., Penman, B., Lee, L. N., Odon, V., Mongkolsapaya, J., Chinnakannan, S., Dejnirattisai, W., Edmans, M., Fyfe, A., Imlach, C., Kooblall, K., Lim, N., Liu, C., Lopez-Camacho, C., McInally, C.-A., Ramamurthy, N., Ratcliff, J., Supasa, P., Wang, B., Mentzer, A. J., Turner, M., Semple, C., Baillie, J. K., ISARIC4C Investigators, , Harvala, H., Screaton, G., Temperton, N., Klenerman, P., Jarvis, L., Gupta, S., Simmonds, P.
10.1101/2020.04.13.20060467 — Posted: 2020-04-17
The effect of Arbidol Hydrochloride on reducing mortality of Covid-19 patients: a retrospective study of real world date from three hospitals in Wuhan
Liu, Q., Fang, X., Tian, L., Chen, X., Chung, U., Wang, K., Li, D., Dai, X., Zhu, Q., Xu, F., Shen, L., Wang, B., Yao, L., Peng, P.
10.1101/2020.04.11.20056523 — Posted: 2020-04-17 Discussion: Onsite
Long-term Co-existence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) with Antibody Response in Non-severe Coronavirus Disease 2019 (COVID-19) Patients
Wang, B., Wang, L., Kong, X., Geng, J., Xiao, D., Ma, C., Jiang, X., Wang, P.-H.
10.1101/2020.04.13.20040980 — Posted: 2020-04-17 Discussion: Onsite
Improving Coronavirus (COVID-19) Diagnosis using Deep Transfer Learning
Razzak, I., Naz, S., Rehman, A., Khan, A., Zaib, A.
10.1101/2020.04.11.20054643 — Posted: 2020-04-17
Time course quantitative detection of SARS-CoV-2 in Parisian wastewaters correlates with COVID-19 confirmed cases
Wurtzer, S., Marechal, V., Mouchel, J.-M., Moulin, L.
10.1101/2020.04.12.20062679 — Posted: 2020-04-17 Discussion: Onsite
Shotgun proteomics of SARS-CoV-2 infected cells and its application to the optimisation of whole viral particle antigen production for vaccines
Grenga, L., Gallais, F., Pible, O., Gaillard, J.-C., Gouveia, D., Batina, H., Bazaline, N., Ruat, S., Culotta, K., Miotello, G., Debroas, S., Roncato, M.-A., Steinmetz, G., Foissard, C., Desplan, A., Alpha-Bazin, B., Almunia, C., Gas, F., Bellanger, L., Armengaud, J.
10.1101/2020.04.17.046193 — Posted: 2020-04-17 Discussion: Offsite
A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals
Riva, L., Yuan, S., Yin, X., Martin-Sancho, L., Matsunaga, N., Burgstaller, S., Pache, L., De Jesus, P., Hull, M. V., Chang, M., Chan, J. F. W., Cao, J., Kwok-Man Poon, V., Herbert, K., Nguyen, T.-T., Pu, Y., Nguyen, C., Rubanov, A., Martinez-Sobrido, L., Lui, W.-C., Miorin, L., White, K., Johnson, J. R., Benner, C., Sun, R., Schultz, P., Su, A. I., Garcia-Sastre, A., Chatterjee, A., Yuen, K.-Y., Chanda, S.
10.1101/2020.04.16.044016 — Posted: 2020-04-17 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).